Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Go back to Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products| SIMULATIONS PLUS, Inc. (NASDAQ: SLP) | Delayed: 18.17 +0.07 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.10 | 52 Week High | $11.89 | |||
| Open | $18.20 | 52 Week Low | $6.74 | |||
| Day High | $18.27 | P/E | 100.94 | |||
| Day Low | $18.14 | EPS | $0.18 | |||
| Volume | 294,506 | |||||
